Investor777的博客
極限炒股法-分為2部分: 1)穩健型投資 2)超激進型投資-每月使之翻倍.Email: info@Investor777.com
正文
Investor777 (08/22/2009)
I would like to discuss several stocks with great potentials. Please note, the risk/reward comments here are relative to the other stocks. And they will change when time/price change.
1. 3 kingkong (high risk high reward)
FNM/FRE/AIG – pulled back with long uptail, be cautious, still have huge upside momentum
2. 1 grey horse (huge risk high reward)
CTIC – has risen 3280% from the annual low 2009, in retracement, seems ready to launch again. Please track the reaction to the news below next week:
NEW YORK (AP) -- Cell Therapeutics, Inc. said Friday it received $28.2 million from a sale of stock to a single investor.
The Seattle-based company said the investor bought Series 2 Preferred Stock shares, which were then converted to 18.9 million shares of common stock.
The investor also received warrants to buy up to 4.7 million additional shares of common stock at an exercise price of $1.70 per warrant share. The warrants, which could generate $8 million in proceeds for the company, will expire in nine months.
3. 2 king gamblers (mid risk mid reward)
LVS/MGM – reach resistance again, will rise again after consolidation. I called LVS/MGM Monday on DQ after the big pullback on 08/14/2009. And I urged all people who emailed me to buy when LVS was close to 12/MGM close to 8 Tuesday (08/18/2009). I even sent plan out to people to buy LVS near 11$, should panic drop happen (of course it did not happen). Many friends bought LVS (or bought it again) near 12$ last week, congratulations!
Sorry, I can not send you QQH one by one, for those who did not provide email in their QQH.
Below is automated translation in Chinese, which may not be accurate, FYI only.
Happy trading!
我想討論幾個有潛力的股票。
請注意，風險/回報的評論在這裏是相對於其他股票。他們將改變，隨時間/價格的變化。
1。 3 大金剛（高風險高回報）
FNM / FRE/ AIG 衝高回落，仍有巨大的上揚勢頭， 在周5大盤創2009新高時帶長上影收盤，需當心。
2。 1匹灰馬 （巨大的風險高回報）
CTIC 已從2009年的 最低上升3280％, 衝高回落，似乎準備再次發射。請跟蹤下麵消息 (ZT)：公司申請擴大淋巴瘤藥Zin的適應症；Opaxio(聚穀氨酸紫杉醇)目前正在歐洲接受審評，申請作為一線療法用於治療非小細胞肺癌；遞交Pixantrone用於非何傑金氏淋巴瘤的上市申請，希望年末獲批。非何傑金氏淋巴瘤美國每年有近10萬病例。而Opaxio的市場更大，目前紫杉醇的市場為20多億美元。兩隻新藥是否被批準，年底揭曉。目前距離年底有一段時間，有充足的時間適應市場炒作。公司另有1個新藥處於PHASE II。
3。 2位賭神（中風險中回報）
LVS/MGM-再次達到阻力，調整後將再次上升。
我 再次在2009年8月14日周一之後的大回落後於DQ推薦LVS/MGM。我給所有給我發電子郵件的朋友說(抱歉，我不能給所有未提供email的朋友一一回信)，購買LVS接近12$/ MGM接近8$ 星期二（2009年8月18日）。我甚至發出推薦操作計劃：購買11美元附近的LVS，如果出現恐慌下降（當然這沒有發生）。上周許多朋友買了LVS近12美元（或再次買了），祝賀！
再次抱歉，我不能給所有未提供 email的朋友一一回悄悄話。
上麵是自動翻譯的中文，這可能不準確，僅供參考
祝大家過得愉快！
I would like to discuss several stocks with great potentials. Please note, the risk/reward comments here are relative to the other stocks. And they will change when time/price change.
1. 3 kingkong (high risk high reward)
FNM/FRE/AIG – pulled back with long uptail, be cautious, still have huge upside momentum
2. 1 grey horse (huge risk high reward)
CTIC – has risen 3280% from the annual low 2009, in retracement, seems ready to launch again. Please track the reaction to the news below next week:
NEW YORK (AP) -- Cell Therapeutics, Inc. said Friday it received $28.2 million from a sale of stock to a single investor.
The Seattle-based company said the investor bought Series 2 Preferred Stock shares, which were then converted to 18.9 million shares of common stock.
The investor also received warrants to buy up to 4.7 million additional shares of common stock at an exercise price of $1.70 per warrant share. The warrants, which could generate $8 million in proceeds for the company, will expire in nine months.
3. 2 king gamblers (mid risk mid reward)
LVS/MGM – reach resistance again, will rise again after consolidation. I called LVS/MGM Monday on DQ after the big pullback on 08/14/2009. And I urged all people who emailed me to buy when LVS was close to 12/MGM close to 8 Tuesday (08/18/2009). I even sent plan out to people to buy LVS near 11$, should panic drop happen (of course it did not happen). Many friends bought LVS (or bought it again) near 12$ last week, congratulations!
Sorry, I can not send you QQH one by one, for those who did not provide email in their QQH.
Below is automated translation in Chinese, which may not be accurate, FYI only.
Happy trading!
我想討論幾個有潛力的股票。
請注意，風險/回報的評論在這裏是相對於其他股票。他們將改變，隨時間/價格的變化。
1。 3 大金剛（高風險高回報）
FNM / FRE/ AIG 衝高回落，仍有巨大的上揚勢頭， 在周5大盤創2009新高時帶長上影收盤，需當心。
2。 1匹灰馬 （巨大的風險高回報）
CTIC 已從2009年的 最低上升3280％, 衝高回落，似乎準備再次發射。請跟蹤下麵消息 (ZT)：公司申請擴大淋巴瘤藥Zin的適應症；Opaxio(聚穀氨酸紫杉醇)目前正在歐洲接受審評，申請作為一線療法用於治療非小細胞肺癌；遞交Pixantrone用於非何傑金氏淋巴瘤的上市申請，希望年末獲批。非何傑金氏淋巴瘤美國每年有近10萬病例。而Opaxio的市場更大，目前紫杉醇的市場為20多億美元。兩隻新藥是否被批準，年底揭曉。目前距離年底有一段時間，有充足的時間適應市場炒作。公司另有1個新藥處於PHASE II。
3。 2位賭神（中風險中回報）
LVS/MGM-再次達到阻力，調整後將再次上升。
我 再次在2009年8月14日周一之後的大回落後於DQ推薦LVS/MGM。我給所有給我發電子郵件的朋友說(抱歉，我不能給所有未提供email的朋友一一回信)，購買LVS接近12$/ MGM接近8$ 星期二（2009年8月18日）。我甚至發出推薦操作計劃：購買11美元附近的LVS，如果出現恐慌下降（當然這沒有發生）。上周許多朋友買了LVS近12美元（或再次買了），祝賀！
再次抱歉，我不能給所有未提供 email的朋友一一回悄悄話。
上麵是自動翻譯的中文，這可能不準確，僅供參考
祝大家過得愉快！
評論
optionguy
2009-09-16 11:36:27
回複
悄悄話
very well written.......... can you comment on shippers when you have chance, thanks
登錄後才可評論.
